The Nuclear Energy Agency’s High-Level Group on Low Dose Research (HLG-LDR) RAD/CHEM AOP joint topical group is undertaking an international effort to identify the most important open questions regarding the use of the Adverse Outcome Pathway (AOP) framework in radiation research and regulation. This effort is being funded through the Canadian Organization on the Health Effects from Radiation Exposure (COHERE) and guided by an international steering committee (background information on the AOPs)
This voluntary survey https://AOP25.sawtoothsoftware.com/login.html (completion time ~20-30 minutes) seeks opinions on the scope of AOPs in the field of radiation research and regulation. The results will help understanding of how science priorities vary within and among different domains of research and this information will be used by the RAD/CHEM AOP joint topical group to help evolve AOP use in radiation research and regulation. All information collected will be aggregated for analysis; the aggregate data analysis will not be identifiable to any individual contribution.
Please note that the survey will be live for 5 weeks.